NASDAQ:ACRV | Income Statement | Acrivon Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$13.84M$18.67M-$18.67M$704,000.00-$17.96M-$0.43-$0.4341,841,88741,841,887
2026-03-31$15.17M$19.9M-$19.9M$860,000.00-$19.04M-$0.49-$0.4938,724,80338,724,803
2025-12-31$14.75M$20.12M-$20.12M$1.13M-$18.99M-$0.49-$0.4951,00251,002
2025-09-30$13.65M$19.69M-$19.69M$1.45M-$18.23M-$0.47-$0.4738,560,46438,560,464
2025-06-30$16.18M$22.65M-$22.65M$1.64M-$21.01M-$0.55-$0.5538,461,61938,461,619
2025-03-31$15.41M$21.66M-$21.66M$1.98M-$19.68M-$0.51-$0.5138,350,44438,350,444
2024-12-31$18.63M$24.95M-$24.95M$2.12M-$22.83M-$0.59-$0.591,494,3601,494,360
2024-09-30$18.86M$25.14M-$25.14M$2.7M-$22.44M-$0.59-$0.5938,105,13138,105,131
2024-06-30$15.03M$21.44M-$21.44M$2.64M-$18.8M-$0.52-$0.5236,132,61636,132,616
2024-03-31$11.47M$17.67M-$17.67M$1.18M-$16.49M-$0.73-$0.7322,590,80422,590,804
2023-12-31$15.48M$21.05M-$21.05M$1.8M-$19.25M-$0.87-$0.8786,68186,681
2023-09-30$10.27M$16.14M-$16.14M$1.67M-$14.47M-$0.66-$0.6622,081,16222,081,162
2023-06-30$10.52M$15.52M-$15.52M$1.61M-$13.91M-$0.63-$0.6321,971,03221,971,032
2023-03-31$9.76M$14.39M-$14.39M$1.64M-$12.76M-$0.58-$0.5821,920,57021,920,570
2022-12-31$9.95M-$9.95M$1.02M-$8.93M$4.99$4.992,349,4212,349,421
2022-09-30$9.58M-$9.58M$377,000.00-$9.2M-$5.17-$5.171,778,2551,778,255
2022-06-30$5.93M-$5.93M$105,000.00-$5.82M-$3.29-$3.291,769,5611,769,561
2022-03-31$7.21M-$7.21M-$8,000.00-$7.22M-$4.08-$4.081,769,5611,769,561
2021-12-31$4.27M-$4.27M-$73,000.00-$4.34M-$2.46-$2.468,8228,822
2021-09-30$2.67M-$2.67M$231,000.00-$2.44M-$1.38-$1.381,769,1321,769,132
2021-06-30-$2.55M
2021-03-31-$6.91M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$59.99M$84.11M-$84.11M$6.21M-$77.83M$0.00-$77.91M-$2.02-$2.0238,509,28138,509,281
2024-12-31$63.99M$89.2M-$89.2M$8.64M-$80.44M-$80.56M-$2.38-$2.3833,791,81733,791,817
2023-12-31$46.02M$67.1M-$67.1M$6.72M-$60.39M-$2.74-$2.7422,078,19022,078,190
2022-12-31$23.95M$32.66M-$32.66M$1.49M-$31.17M-$7.56-$7.564,121,9124,121,912
2021-12-31$16.18M-$16.18M-$59,000.00-$16.24M-$9.32-$9.321,743,3821,743,382